TP53 and cancer: Western blot analysis of protein extracts showed variable alterations in p53 levels in all cancer samples, with significant increases at densitometry in PDTCs ones compared to goiters ones (7.671±1.198 vs. 1.989±0.2921, respectively, p < 0.01).